SCHEMBL577736

SCHEMBL577736

C[n+]1ccc(C#N)cc1.Fc1c(F)c(F)c([B-](c2c(F)c(F)c(F)c(F)c2F)(c2c(F)c(F)c(F)c(F)c2F)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 6/20 0.67
▸ CYP2A6 P11509 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.34
▸ SLC22A2 O15244 1/20 0.33
▸ SLC22A1 O15245 1/20 0.33
▸ SLC22A3 O75751 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ KIF11 P52732 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ MAOB P27338 1/20 0.31
▸ CA12 O43570 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CA3 P07451 1/20 0.30
▸ CA6 P23280 1/20 0.30
▸ CA9 Q16790 1/20 0.30
▸ CA14 Q9ULX7 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8336432 0.82 HDAC8 (0.69) HDAC8CYP2A6TSHR
SCHEMBL5455838 0.82 — —
Iodide SCHEMBL7051892 0.80 HDAC8 (0.95) HDAC8CYP2A6ALDH1A1SLC22A2SLC22A1
Hydrochloric Acid SCHEMBL5831783 0.80 HDAC8 (0.95) HDAC8CYP2A6ALDH1A1SLC22A2SLC22A1
Iodide SCHEMBL23131037 0.80 HDAC8 (0.95) HDAC8CYP2A6ALDH1A1SLC22A2SLC22A1
Iodide SCHEMBL23131038 0.80 HDAC8 (0.95) HDAC8CYP2A6ALDH1A1SLC22A2SLC22A1
SCHEMBL9018416 0.77 HDAC8 (0.50) HDAC8SLC22A2SLC22A1SLC22A3SLC6A4
Isonicotinonitrile SCHEMBL1135040 0.76 TSHR (0.33) HDAC8CYP2A6ALDH1A1TSHRCA12
SCHEMBL6238003 0.74 HDAC8 (0.67) HDAC8CYP2A6ALDH1A1SLC22A2SLC22A1
SCHEMBL23131039 0.74 HDAC8 (0.82) HDAC8CYP2A6ALDH1A1SLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6169152-B1 COPOLYMER OF ETHYLENE AND A POLAR GROUP-CONTAINING CYCLIC OLEFIN COMPRISING ESTER- OR ANHYDRIDE MODIFIED NORBORNENE OR PERHYDRO-2,3-DIDEHYDRO-1,4:5,8-DIMETHANONAPHTHALENE MADE WITH CATALYST SUCH AS 1,5,9-TRIAZACYCLODODECANYLTITANIUM CHLORIDE JSR CORPORATION (JP) 2001-01-02 — — US claimed
US-5444134-A Using a coordination catalyst IDEMITSU KOSAN CO., LTD. (JP) 1995-08-22 — — US claimed
US-6414090-B1 — — None — — US disclosed
US-20240308936-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-09-19 — — US disclosed
EP-4385972-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2024-06-19 — — EP disclosed
WO-2024116789-A1 LUBRICATING OIL COMPOSITION 出光興産株式会社 2024-06-06 — — WO disclosed
EP-3626869-B1 CRIMPED FIBERS AND NONWOVEN CLOTH IDEMITSU KOSAN CO (JP) 2024-04-24 — — EP disclosed
CN-117795038-A Process for producing alpha-olefin oligomer composition 出光兴产株式会社 2024-03-29 — — CN disclosed
US-20230235202-A1 PLASTICIZER FOR RESINS IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-27 — — US disclosed
CN-110494486-B Polypropylene resin composition, pellet, and molded article 出光兴产株式会社 2022-08-26 — — CN disclosed
US-11034826-B2 Polypropylene-based resin composition, pellet, and molded object IDEMITSU KOSAN CO., LTD. (JP) 2021-06-15 — — US disclosed
EP-0571987-A2 Process for producing an ethylenic polymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 — — EP disclosed
EP-0572003-A2 Process for producing an ethylenic polymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 — — EP disclosed
EP-0572034-A2 Ethylenic copolymer and ethylenic copolymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 — — EP disclosed
EP-0570931-A2 Styrenic polymer, process for producing same and multi-layer material comprising same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 — — EP disclosed
EP-0570932-A2 Styrenic block copolymer and process for producing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 — — EP disclosed
EP-0559108-A1 Graft copolymer, process for production thereof and resin composition containing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-09-08 — — EP disclosed
EP-0522581-A1 Process for producing olefin based polymers and olefin polymerization catalyst IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-01-13 — — EP disclosed
EP-0513380-A1 PROCESS FOR PRODUCING OLEFINIC POLYMER IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-11-19 — — EP disclosed
EP-0504418-A1 PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER, CYCLOOLEFIN COPOLYMER, AND COMPOSITION AND MOLDING PREPARED THEREFROM IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-09-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240308936-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION OXER1, AMY1A, MACF1 HDAC8 3963/4885CYP2A6 1150/4885ALDH1A1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback